Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 14,186 | 1,520 | 10,114 | 1,905 | 1,806 |
| Cost of Goods | N/A | N/A | 1,478 | N/A | N/A |
| Gross Profit | 14,186 | 1,520 | 8,636 | 1,905 | 1,806 |
| Operating Expenses | 30,897 | 28,636 | 28,283 | 25,390 | 28,967 |
| Operating Income | -16,711 | -27,116 | -19,169 | -23,485 | -27,161 |
| Interest Expense | 1,692 | 1,553 | 678 | 351 | 0 |
| Other Income | -958 | 364 | 340 | 13 | 20 |
| Pre-tax Income | -19,361 | -28,305 | -19,507 | -23,823 | -27,141 |
| Net Income Continuous | -19,361 | -28,305 | -19,507 | -23,823 | -27,141 |
| Net Income | $-19,361 | $-28,305 | $-19,507 | $-23,823 | $-27,141 |
| EPS Basic Total Ops | -0.52 | -0.77 | -0.53 | -0.65 | -0.74 |
| EPS Basic Continuous Ops | -0.52 | -0.77 | -0.53 | -0.65 | -0.74 |
| EPS Diluted Total Ops | -0.52 | -0.77 | -0.53 | -0.65 | -0.74 |
| EPS Diluted Continuous Ops | -0.52 | -0.77 | -0.53 | -0.65 | -0.74 |
| EBITDA(a) | $-16,719 | $-26,857 | $-18,911 | $-23,288 | $-27,076 |